Consultation News and Research

RSS

Practice Research Award winner describes research to support pharmacist prescribing services

"Doctors who have worked with, and patients receiving care provided by, pharmacist prescribers are highly supportive and value their prescribing roles but research indicates that the service is not being optimised due to a lack of strategic direction and policies to support its place in patient care" said Professor Derek Stewart in his keynote lecture as the winner of the Pharmacy Practice Research Trust (PPRT) 2011 Practice Research Award at the Royal Pharmaceutical Society's Conference in London.

16 Sep 2011

Telestroke appears to be cost-effective for rural hospitals

In a first of its kind study, researchers have found that using two way audio-video telemedicine to deliver stroke care, also known as telestroke, appears to be cost-effective for rural hospitals that don't have an around-the-clock neurologist, or stroke expert, on staff.

15 Sep 2011

U.N. agencies, Pakistan government launch rapid needs assessment, provide aid in flood-affected regions

"United Nations humanitarian agencies have begun to assist communities in southern Pakistan that have been pummeled by monsoon rains which have claimed the lives of almost 200 people and destroyed or damaged nearly one million homes in an area still recovering from last year's catastrophic floods," the U.N. News Centre reports.

13 Sep 2011

Wrapping cigarettes in plain packaging helps remove appeal of smoking

Removing branding and wrapping cigarettes in plain packaging helps remove the appeal of smoking according to new a Cancer Research UK-funded study published in Tobacco Control.

9 Sep 2011

HRSA announces $5.1M in awards as part of Ryan White HIV/AIDS Program

The Health Resources and Services Administration (HRSA) today announced awards of $5.1 million to provide training and technical assistance (TA) as part of the Ryan White HIV/AIDS Program, which provides HIV-related services in the United States for those who do not have sufficient health care coverage or financial resources for coping with HIV disease.

8 Sep 2011

Gilead to amend design of ongoing clinical trials against chronic hepatitis C

Gilead Sciences, Inc. today announced that, in consultation with the U.S. Food and Drug Administration (FDA), the company will amend the design of ongoing clinical trials to discontinue dosing of GS 9190 in hepatitis C-infected patients who are receiving that compound in combination with pegylated interferon and ribavirin, and another direct-acting antiviral agent.

5 Sep 2011

ACS' Commission on Cancer releases new standards to directly address patient concerns

A patient-centered approach is at the forefront of new accreditation standards for hospital cancer programs released today by the Commission on Cancer (CoC) of the American College of Surgeons.

2 Sep 2011

Leucine may help people burn fat during periods of food restriction

Research on Mt. Everest climbers is adding to the evidence that an amino acid called leucine - found in foods, dietary supplements, energy bars and other products - may help people burn fat during periods of food restriction, such as climbing at high altitude, while keeping their muscle tissue.

29 Aug 2011

AAO-HNSF's 2011 Annual Meeting & OTO EXPO to convene in San Francisco

The 2011 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, will convene September 11-14, 2011, in San Francisco, CA.

29 Aug 2011

Concrete regulations on health data protection needed

What happens if the seropositive condition of a patient is leaked? What social and work consequences might this involve? This is just one example that illustrates the importance of regulating health data protection. Mr Unai Aberasturi, a jurist at the University of the Basque Country (UPV/EHU), has made a study of what the Spanish Statute Law on Data Protection (LOPD in its Spanish acronym) says about this, drawing the conclusion that, normally, this is left open to interpretation.

26 Aug 2011

Clay modelling could help disturbed teenagers deal with mental health problems

Researchers at The University of Nottingham are to investigate whether the therapeutic effects of clay modelling could help disturbed teenagers deal with their feelings of anger, anxiety and depression.

24 Aug 2011

FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL

Seattle Genetics, Inc. today announced that the U.S. Food and Drug Administration has granted accelerated approval of ADCETRISTM for two indications: (1) the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, and (2) the treatment of patients with systemic anaplastic large cell lymphoma after failure of at least one prior multi-agent chemotherapy regimen.

20 Aug 2011

Time-release corticosteroid implant effective in treating uveitis

A team of researchers comparing the two leading treatment approaches for the eye condition uveitis, which is the fifth leading cause of blindness in the US, have found that a time-release corticosteroid implant placed surgically in the eye is similarly effective in treating the disease as anti-inflammatory corticosteroids and immunosuppressive drugs taken orally. The report was published online this week in the journal Ophthalmology.

19 Aug 2011

Longer looks: Doctors advocating less care; addiction as a 'disease'

These physicians are not anti-medicine. They are not trying to save money on their copayments or deductibles. And they are not trying to rein in the nation's soaring health-care costs, which at $2.7 trillion account for fully one sixth of every dollar spent in the U.S. They are applying to their personal lives a message they have become increasingly vocal about in their roles as biomedical researchers and doctors: more health care often means worse health.

19 Aug 2011

Paladin to acquire Labopharm

Paladin Labs Inc. and Labopharm Inc. announced today that they have entered into a definitive agreement pursuant to which Paladin will acquire all of the issued and outstanding common shares of Labopharm at a price of $0.2857 per share in cash, which represents a premium of 57.4% over the volume-weighted average price of Labopharm's shares of $0.1815 for the 30 trading days prior to this announcement.

18 Aug 2011

State roundup: Health insurance ruling reverberates; Fla. to accept some health law funds; California's aging issues

The state has returned millions in health reform dollars for child and elder care programs, among other things. But on Monday, HHS awarded the Sunshine State $1.26 million in ACA money to bolster efforts to report and combat infectious diseases.

17 Aug 2011

New study looks at the role CTS patients play in medical decision-making process

Patients receiving treatment for carpal tunnel syndrome (CTS) prefer to play a more collaborative role when it comes to making decisions about their medical or surgical care, according to the findings of an August 3rd issue of the Journal of Bone and Joint Surgery.

9 Aug 2011

RACGP urging the government to restore mental health rebates

In its submission to the Senate Standing Committee on Community Affairs regarding the Commonwealth funding and administration of mental health services, the Royal Australian College of General Practitioners (RACGP) strongly argued for the restoration of GP mental health services. The College is gravely concerned regarding the proposed cuts to the Better Access program and the subsequent impact on mental health delivery for every patient age group, demographic and geography throughout Australia.

3 Aug 2011

Celldex second quarter net loss increases to $10.2 million

Celldex Therapeutics, Inc. today reported financial results for the second quarter ended June 30, 2011. Celldex reported a net loss of $10.2 million, or $0.27 per share, for the second quarter of 2011 compared to a net loss of $9.5 million, or $0.30 per share, for the second quarter of 2010.

3 Aug 2011

Tunstall Healthcare launch new myclinic@home telehealth solution

myclinic@home is the latest in telehealth solutions, allowing remote patients to easily monitor their vital signs and manage a long term health condition in the comfort of their own home or a clinic setting, all supported by a health professional.

1 Aug 2011